Anticoagulation in the Trauma Patient

Accreditation Statement: The Orthopaedic Trauma Association (OTA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation:  OTA designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Learning Objectives

After completing this activity, learners will be able to:

1. Review the scope and gravity of the problem of DVT and PE in the trauma patient population
2. Understand the available anticoagulation and antiplatelet medications available for use
3. Discuss the management of DVT prophylaxis in the initial presentation, perioperative, and postoperative setting. 

Faculty

• Moderator: Paul Goodwyn, MD
  Matthew Wharton, MD, William Obremskey, MD, Michael McKee, MD

Original release date: 11/30/2022

Expiration date: 11/30/2025

Estimated time to complete activity: 1 hour

Statement of Need/Description/or Summary of Gap Analysis

This webinar will provide the tools for thoughtful anticoagulation management recommendations in the orthopaedic trauma patient population  

Instructional Format: Online webcast consisting of slides and audio.

Method of Participation: There are no fees for members to participate in this activity. Non-members must pay $40. To participate in the activity, physicians will be required to take the following steps:

• Read the learning objectives and faculty disclosures.
• Participate in the activity.
• Complete the activity evaluation.
• Participants who successfully complete the evaluation will receive AMA PRA Category 1 Credits™.

Disclosures:

The Orthopaedic Trauma Association has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education requiring mitigation of all conflicts of interest. Faculty declaring a relevant commercial interest must be identified in the activity syllabus and/or program.

In accordance with disclosure policies of OTA and the ACCME, every effort has been made to ensure all CME activities are balanced, independent, objective, and scientifically rigorous. These policies include complying with ACCME’s Standards for Integrity and Independence in Accredited Continuing Education and mitigating all relevant conflicts of interest for all individuals in control of content.  

All of the relevant financial relationships listed for these individuals have been mitigated

Disclosures are available on the "Disclosure" tab.

Disclaimer: The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by the OTA.  In no event will the OTA be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Commercial Support: There is no commercial support for this activity